Floatz logo

Viosterol

Impaired Renal Function Disease

Brigham and Women's HospitalSmall moleculePhase 3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Impaired Renal Function Disease cohort.

Asset / SponsorPhaseRating
Probenecid
Brigham and Women's Hospital
Phase 3BB
Allopurinol
Brigham and Women's Hospital
Phase 3B
Tenofovir Alafenamide
Thomas Jefferson University
UnknownD

Same molecule, other indications

Viosterol is also rated in:

secondary hyperparathyroidismDormant
BB
Indicative · Phase 4
64 / 100
View asset →
essential hypertensionDormant
B
Indicative · Phase 3
61 / 100
View asset →
vitamin D deficiencyActive
B
Indicative · Phase 4
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →